Pancreatic Cancer Research

ResearcherUniversity of Bari Aldo MoroActive in the last 2 years

Rosa Angela Cardone

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2011-9135; OpenAlex author ID A5043434300. Sources: OpenAlex.

Their work

Papers
16 (first author 2, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
47
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: 3 papers · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 16

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry. Last author DOI 10.3390/cells15100865↗
  3. Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction? Co-author DOI 10.1016/j.abb.2025.110291↗
  4. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. First author DOI 10.3390/cells13070602↗
  5. Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemc… Last author DOI 10.3390/cells13090730↗
  6. Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLAD1 gene expression: the inhibitory effec… Co-author DOI 10.1111/febs.16881↗
  7. Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro. Co-author DOI 10.3390/cancers15092572↗
  8. Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell. Last author DOI 10.3390/cancers15153868↗
  9. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Last author DOI 10.3390/cancers14102486↗
  10. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition. Last author DOI 10.3390/cancers14153737↗
  11. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as The… Last author DOI 10.3390/cancers13236135↗
  12. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. Last author DOI 10.3390/ijms22083953↗
  13. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth. Co-author DOI 10.1038/s42255-020-00315-1↗
  14. Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine. Last author DOI 10.3390/ijms22010029↗
  15. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome. Last author DOI 10.1111/febs.14471↗
  16. Assessment of different 3D culture systems to study tumor phenotype and chemosensitivity in pancreatic ductal adenocarcinoma. First author DOI 10.3892/ijo.2016.3513↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephan J. Reshkin · 15 shared papers, 2016–2026 · strength 2.49
  2. Tiago M. A. Carvalho · 10 shared papers, 2020–2026 · strength 1.64
  3. Maria Raffaella Greco · 10 shared papers, 2016–2026 · strength 1.42
  4. Tomas Koltai · 5 shared papers, 2021–2024 · strength 1.06
  5. Stefania Cannone · 4 shared papers, 2018–2026 · strength 0.68
  6. Natalia B. Prevarskaya · 3 shared papers, 2023–2026 · strength 0.53
  7. Madelaine Magalì Audero · 3 shared papers, 2023–2026 · strength 0.53
  8. Alessandra Fiorio · 3 shared papers, 2023–2026 · strength 0.53
  9. Maria Barile · 2 shared papers, 2023–2025 · strength 0.43
  10. Alessia De Nisco · 2 shared papers, 2023–2025 · strength 0.43
  11. Albrecht Schwab · 2 shared papers, 2023–2026 · strength 0.34
  12. Katrine Zeeberg · 3 shared papers, 2016–2022 · strength 0.29
  13. Silvia Arpicco · 2 shared papers, 2020–2024 · strength 0.28
  14. Frauke Alves · 2 shared papers, 2016–2026 · strength 0.25
  15. Stine F. Pedersen · 2 shared papers, 2016–2026 · strength 0.25
  16. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  17. Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
  18. Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
  19. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  20. Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
  21. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  22. Julie Schnipper · 1 shared paper, 2026 · strength 0.19
  23. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
  24. Ganga Deshar · 1 shared paper, 2026 · strength 0.19
  25. Ivana Novak · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.